Catalysis can be pivotal in designing therapeutic interventions for hypoglycemia. By enhancing the activity of enzymes involved in glucose production or inhibiting those responsible for glucose depletion, we can maintain optimal blood glucose levels. For example, inhibitors of insulin-degrading enzymes can prolong the action of insulin, thereby preventing rapid drops in blood glucose.
